Screener
Boston Scientific BSX Cardiovascular — Total assets of reportable segments
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Boston Scientific in its filing.
Tagged under the XBRL concept us-gaap:OtherAssets.
The source filing: Boston Scientific’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 6:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885725-26-000033
| Total assets (in millions) | As of / March 31, 2026 | As of / December 31, 2025 |
|---|---|---|
| MedSurg | $3,726 | $3,392 |
| Cardiovascular | 8,251 | 7,999 |
| Total assets of reportable segments | 11,977 | 11,391 |
| Goodwill | 18,536 | 18,282 |
| Other intangible assets, net | 7,060 | 7,019 |
| All other corporate assets | 6,778 | 6,981 |
| $44,351 | $43,673 |
ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Boston Scientific's cardiovascular — total assets of reportable segments?
- Boston Scientific (BSX) reported cardiovascular — total assets of reportable segments of $8.25B in Q1 2026.
- How has Boston Scientific's cardiovascular — total assets of reportable segments changed year-over-year?
- Boston Scientific's cardiovascular — total assets of reportable segments increased by 11.3% year-over-year, from $7.41B to $8.25B.
- What does cardiovascular — total assets of reportable segments mean?
- This metric represents the total book value of assets directly employed by the cardiovascular segment to generate revenue. It includes property, plant, equipment, and other segment-specific assets used in the production and distribution of cardiovascular products.
Ask your AI about Boston Scientific's cardiovascular — total assets of reportable segments.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude